TKNO
TKNO
NASDAQ · Life Sciences Tools & Services

Alpha Teknova Inc

$8.21
-0.09 (-1.02%)
Financial Highlights (FY 2026)
Revenue
50.10M
Net Income
-21,338,473
Gross Margin
33.2%
Profit Margin
-42.6%
Rev Growth
-0.7%
D/E Ratio
0.19
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 33.2% 33.2% 29.7% 29.7%
Operating Margin -41.9% -37.7% 12.9% 14.3%
Profit Margin -42.6% -40.5% 8.2% 10.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 50.10M 50.46M 45.50M 44.98M
Gross Profit 16.62M 16.74M 13.53M 13.37M
Operating Income -20,990,286 -19,030,177 5.88M 6.44M
Net Income -21,338,473 -19,345,850 3.71M 4.53M
Gross Margin 33.2% 33.2% 29.7% 29.7%
Operating Margin -41.9% -37.7% 12.9% 14.3%
Profit Margin -42.6% -40.5% 8.2% 10.1%
Rev Growth -0.7% -0.7% +8.6% +16.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 41.37M 41.37M 10.30M 10.23M
Total Equity 216.84M 216.84M 71.30M 78.98M
D/E Ratio 0.19 0.19 0.14 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -19,566,328 -18,724,701 8.38M 7.20M
Free Cash Flow — — 3.81M 2.92M